Methotrexate for Treatment of Tubal Pregnancy.

Baek, Seung Yeob; Park, Cheol Hoon; Kim, Yong Wook; Kim, Gil Joong; Kim, Tae Eung; Ro, Duck Yeong; Jung, Jae Keun

Search: Korean J Obstet Gynecol Search

CLOSE

Original Article

Korean Journal of Obstetrics & Gynecology 2003;46(11):2118-2122.
Published online November 1, 2003.

Methotrexate for Treatment of Tubal Pregnancy.

Seung Yeob Baek, Cheol Hoon Park, Yong Wook Kim, Gil Joong Kim, Tae Eung Kim, Duck Yeong Ro, Jae Keun Jung

Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Abstract

OBJECTIVE
The purpose of this study was to evaluate value of methotretrexate (MTX) in the treatment of tubal pregnancy. METHODS: 28 patients with unruptured tubal pregnancy were treated alternately with four doses of intramuscular MTX (1.0 mg/kg) and four doses of intramuscular citrovorum factor (0.1 mg/kg). Patients considered eligible for MTX treatment of tubal pregnancy were those with unruptured tubal pregnancy

Key Words: Methotrexate, Tubal pregnancy

TOOLS

Full text via DOI
Download Citation

Share :

METRICS

917 View
10 Download

Related articles in Obstet Gynecol Sci

Clinical effect of methotrexate treatment on the urruptured tubal pregnancy.1991 March;34(3)

Three cases of ovarian pregnancy.1992 March;35(3)

Three cases of advanced tubal pregnancy.1992 March;35(3)

A case report of splenic pregnancy.1992 July;35(7)

Conservative treatment of unruptured tubal pregnancy.1993 February;36(2)

ABOUT

ARTICLE & TOPICS

Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES

POLICY

FOR CONTRIBUTORS

Editorial Office: 4th Floor, 36 Gangnam-daero 132-gil, Gangnam-gu, Seoul 06044, Korea.
Tel: +82-2-2266-7238 Fax: +82-2-3445-2440 E-mail: journal@ogscience.org